DTC（Direct-To-Consumer）遺伝子検査市場- 世界の産業規模、動向、機会、予測、検査タイプ別、技術別、サンプル別、流通チャネル別、地域別、競合別、2019～2029年

世界のDTC（Direct-To-Consumer）遺伝子検査市場は、2023年に15億米ドルと評価され、2029年のCAGRは8.45%で、予測期間中に目覚ましい成長を予測しています。

DTC（Direct-To-Consumer）遺伝子検査市場は、医療と消費者ゲノミクスが交差するダイナミックで急速に発展するセグメントです。DTC（Direct-To-Consumer）遺伝子検査では、医療専門家の関与なしに、個人が自分自身に関する遺伝子情報に直接アクセスします。

DTC（Direct-To-Consumer）遺伝子検査市場の核心は、自分の遺伝的体質とその健康、家系、形質への影響に興味を持つ個人に提供するアクセシビリティです。消費者は検査キットをオンラインで注文し、自宅で受け取り、DNAサンプル（通常は唾液）を提供し、検査会社にサンプルを返送します。その後、検査会社はDNAを分析し、個人の遺伝情報の様々な側面に関するレポートを作成します。市場の主要促進要因の一つは、健康状態に対する遺伝的素因を理解することへの関心の高まりです。DTC（Direct-To-Consumer）遺伝子検査会社は、ある種のがん、心血管疾患、遺伝性疾患などの症状に対する個人の遺伝的リスクについて洞察を記載しています。この情報は、消費者が自分のライフスタイル、医療、予防対策について、十分な情報を得た上で決断する力を与えてくれます。先祖の遺伝子検査は、個人が自分の遺伝的遺産を探索し、家族の歴史に関する情報を発見できる人気の機能となっています。ゲノミクスの技術的進歩、特にDNAシークエンシングとデータ解析の進歩は、DTC（Direct-To-Consumer）遺伝子検査市場の拡大にさらに重要な役割を果たしています。遺伝子検査結果の正確さと深さの向上は、市場の信頼性と魅力に貢献しています。

この市場は、既存企業、新興企業、有名な消費者向けゲノミクス・ブランドなど、多様な参入企業によって特徴付けられます。これらの企業は多くの場合、特定の健康リスク評価、詳細な家系レポート、形質分析といった独自の機能を提供することで差別化を図っています。データ共有や共同研究のための研究機関や製薬会社との提携は、市場のダイナミズムに貢献しています。

DTC（Direct-To-Consumer）遺伝子検査市場は、課題と倫理的配慮にも直面しています。遺伝子データの取り扱いに関連するプライバシーの問題、機密情報の悪用の可能性、検査結果の正確性などが精査の対象となっています。DTCモデルには遺伝カウンセリングがないため、消費者に対する複雑な遺伝情報の適切な解釈と伝達について疑問が投げかけられています。

主要市場の促進要因

個別化された健康情報に対する消費者の需要

主要市場課題

プライバシーとセキュリティに関する懸念

結果の正確性と解釈

規制と倫理的配慮

遺伝カウンセリングとインフォームド・コンセント

主要市場動向

検査提供とサービスの拡大

遠隔医療と遠隔カウンセリング

セグメント別洞察

検査タイプ別洞察

技術別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のDTC（Direct-To-Consumer）遺伝子検査市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 検査タイプ別（先祖関係検査、予測検査、ニュートリゲノミクス検査、キャリア検査、スキンケア検査、その他）
  • 技術別（一塩基多型（SP）チップ、対象分析、全ゲノムシークエンス（WGS）、その他）
  • サンプル別（唾液、尿、血液、その他）
  • 販売チャネル別（オンライン、オフライン）
  • 地域別
  • 企業別（2023年）
• 市場マップ

第5章 アジア太平洋のDTC（Direct-To-Consumer）遺伝子検査市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 検査タイプ別
  • 技術別
  • サンプル別
  • 流通チャネル別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州のDTC（Direct-To-Consumer）遺伝子検査市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 検査タイプ別
  • 技術別
  • サンプル別
  • 流通チャネル別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米のDTC（Direct-To-Consumer）遺伝子検査市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 検査タイプ別
  • 技術別
  • サンプル別
  • 流通チャネル別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米のDTC（Direct-To-Consumer）遺伝子検査市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 検査タイプ別
  • 技術別
  • サンプル別
  • 流通チャネル別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカのDTC（Direct-To-Consumer）遺伝子検査市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • 検査タイプ別
  • 技術別
  • サンプル別
  • 流通チャネル別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と新興国市場開拓

• 製品発表
• 合併・買収

第12章 世界のDTC（Direct-To-Consumer）遺伝子検査市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• andMe, Inc
• Ancestry.com, LLC
• Color Health, Inc
• Helix, Inc.
• Counsyl, Inc.
• MyHeritage Ltd.
• Living DNA Ltd.
• Mapmygenome India Limited
• Full Genomes Corporation, Inc
• Direct Laboratory Services, LLC

第15章 戦略的提言

第16章 戦略的提言当社について免責事項

Global Direct-To-Consumer (DTC) Genetic Testing Market wasvalued at USD 1.50 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.45% through 2029. The Direct-to-Consumer (DTC) Genetic Testing Market is a dynamic and rapidly evolving sector at the intersection of healthcare and consumer genomics. DTC genetic testing involves individuals directly accessing genetic information about themselves without the involvement of healthcare professionals.

At the core of the DTC Genetic Testing Market is the accessibility it offers to individuals who are curious about their genetic makeup and its implications for health, ancestry, and traits. Consumers can order testing kits online, receive them at home, provide a DNA sample (usually through saliva), and return the sample to the testing company. The company then analyzes the DNA to generate reports on various aspects of the individual's genetic information. One of the key drivers of the market is the rising interest in understanding one's genetic predispositions for health conditions. DTC genetic testing companies provide insights into an individual's genetic risk for conditions such as certain types of cancer, cardiovascular diseases, and hereditary conditions. This information empowers consumers to make informed decisions about their lifestyle, healthcare, and preventive measures. Ancestry testing has become a popular feature, allowing individuals to explore their genetic heritage and discover information about their family history. Technological advancements in genomics, particularly in DNA sequencing and data analysis, have further played a crucial role in the expansion of the DTC Genetic Testing Market. Improvements in the accuracy and depth of genetic testing results contribute to the market's credibility and appeal.

The market is characterized by a diverse range of players, including established companies, startups, and well-known consumer genomics brands. These companies often differentiate themselves by offering unique features such as specific health risk assessments, detailed ancestry reports, or traits analysis. Partnerships with research institutions and pharmaceutical companies for data sharing and collaborative studies contribute to the market's dynamism.

The DTC Genetic Testing Market also faces challenges and ethical considerations. Privacy concerns related to the handling of genetic data, the potential misuse of sensitive information, and the accuracy of test results are subjects of scrutiny. The lack of genetic counseling in the DTC model raises questions about the appropriate interpretation and communication of complex genetic information to consumers.

Key Market Drivers

Consumer Demand for Personalized Health Insights

Consumer demand for personalized health insights stands as the driving force behind the rapid growth and evolution of the Direct-to-Consumer (DTC) Genetic Testing Market. This demand reflects a paradigm shift in healthcare, where individuals are increasingly taking proactive steps to gain a deeper understanding of their genetic makeup and its implications for their well-being. At the core of this driver is the human desire for knowledge-specifically, knowledge about one's own genetic information and its potential impact on health. People are inherently curious about their predispositions to various health conditions, the likelihood of developing certain diseases, and insights into their overall genetic health profile. DTC genetic testing addresses this curiosity by providing individuals direct access to information encoded in their DNA without the need for intermediary healthcare professionals.

The appeal of personalized health insights lies in the empowerment it offers to consumers. Armed with knowledge about their genetic risk factors, individuals can make informed decisions about their lifestyle, health management, and preventive measures. For instance, if a person learns about a heightened genetic susceptibility to a specific condition, they may choose to adopt lifestyle changes, undergo more frequent screenings, or consult with healthcare professionals for targeted preventive strategies. The growing emphasis on preventive healthcare aligns with the demand for personalized genetic insights. Consumers recognize that understanding their genetic predispositions allows for early intervention and proactive measures to mitigate potential health risks. This shift toward a preventive healthcare mindset is reshaping the healthcare landscape, with individuals seeking to leverage genetic information to optimize their health and well-being.

The COVID-19 pandemic has further highlighted the importance of accessible and convenient healthcare services. With lockdowns and restrictions limiting physical interactions, consumers turned to DTC genetic testing as a viable option for gaining health insights from the safety of their homes. The pandemic accelerated the adoption of remote healthcare solutions, and DTC genetic testing emerged as a resilient and adaptable option for individuals seeking health information during challenging times.

Key Market Challenges

Privacy and Security Concerns

Privacy and security concerns pose significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The inherent sensitivity of genetic data raises fears about potential breaches, unauthorized access, and misuse. Consumers worry about the protection of their most personal information. Safeguarding genetic data against cyber threats and ensuring compliance with data protection regulations are paramount. Companies in the DTC genetic testing space must invest in robust security measures, transparent privacy policies, and clear communication to build and maintain consumer trust. Addressing these concerns is essential for the sustainable growth of the market and fostering a secure environment for individuals to explore their genetic information.

Accuracy and Interpretation of Results

The challenge of accuracy and interpretation of results in the Direct-to-Consumer (DTC) Genetic Testing Market stems from the complexity of genetic data and the evolving nature of scientific knowledge. Variability in testing methodologies can lead to discrepancies, and the intricate nature of genetic information demands precision. Ensuring that consumers receive reliable and meaningful insights requires continuous efforts to enhance testing accuracy and improve result interpretation. Striking a balance between providing comprehensive genetic information and maintaining precision is essential to address this challenge and instill confidence in consumers regarding the reliability of their DTC genetic testing outcomes.

Regulatory and Ethical Considerations

Regulatory and ethical considerations pose significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The dynamic regulatory landscape requires companies to navigate evolving frameworks while ensuring compliance and innovation. Ethical concerns revolve around responsible use of genetic information, potential psychological impacts on consumers, and the need for informed consent. Striking a balance between promoting innovation, protecting consumers, and upholding ethical standards is a delicate challenge. Companies must actively engage in transparent communication, adhere to evolving regulatory requirements, and establish ethical guidelines to address these challenges and foster a trustworthy environment for consumers exploring DTC genetic testing services.

Genetic Counseling and Informed Consent

Genetic counseling and obtaining informed consent present significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The absence of direct, in-person genetic counseling within the DTC model raises concerns regarding consumers' capacity to comprehend intricate genetic information and the potential health implications. Ensuring sufficient support and securing informed consent emerge as critical obstacles, particularly given the nuanced nature of genetic data. Balancing accessibility with the necessity for comprehensive understanding presents a formidable challenge. Addressing this challenge entails developing effective methods for providing genetic counseling remotely, thereby empowering consumers with the knowledge required to make informed decisions about their health based on the results of DTC genetic testing.

Key Market Trends

Expanded Test Offerings and Services

The trend of expanded test offerings and services in the Direct-to-Consumer (DTC) Genetic Testing Market signifies a shift beyond traditional health-related insights. Companies are diversifying their portfolios to include a broader range of genetic tests, such as ancestry testing, trait analysis, and wellness assessments. This expansion provides consumers with a more comprehensive understanding of their genetic makeup, catering to diverse interests and preferences. By offering a spectrum of tests, DTC genetic testing services aim to engage a wider audience and meet the evolving demands of consumers who seek a holistic view of their genetic information, extending beyond medical implications to encompass various aspects of personal identity and well-being.

Telehealth and Remote Counseling

The trend of telehealth and remote counseling is gaining prominence in the Direct-to-Consumer (DTC) Genetic Testing Market, addressing the challenge of genetic counseling accessibility. Companies are leveraging digital platforms to provide consumers with convenient access to genetic counseling services remotely. This ensures that individuals receive guidance and support in interpreting complex genetic test results from the comfort of their homes. The integration of telehealth not only enhances the overall consumer experience but also promotes informed decision-making. By embracing remote counseling, DTC genetic testing services are bridging the gap between consumers and genetic expertise, making genetic information more accessible and understandable.

Segmental Insights

Test Type Insights

Basedon the test type, ancestry and relationship testing emerged as the fastest growing segment in the Global Direct-to-Consumer (DTC) Genetic Testing Market due to its broad consumer appeal and non-medical nature. This category provides insights into one's heritage, family origins, and connections with relatives, appealing to a diverse consumer base interested in exploring their ancestral roots. The allure of genealogy, family history, and discovering genetic relatives greatly fuels the popularity of Ancestry and Relationship Testing. This non-clinical emphasis aligns with the increasing trend of consumers seeking a comprehensive understanding of their genetic makeup beyond health-related aspects, making it a significantly growing and widely embraced segment in the DTC genetic testing industry.

Technology Insights

Single Nucleotide Polymorphism (SNP) chips dominate the Global Direct-to-Consumer (DTC) Genetic Testing Market due to their efficiency in providing comprehensive genetic insights at an affordable cost. These chips analyze variations in single nucleotides across the genome, offering a cost-effective method for identifying genetic markers associated with various traits, ancestry, and health conditions. The widespread use of SNP chips enables large-scale genotyping, facilitating the generation of extensive genetic data for consumers. This dominance is driven by the balance of accuracy, affordability, and the ability to cover a broad spectrum of genetic information, making SNP chips a preferred choice in the DTC genetic testing landscape.

Regional Insights

North America asserts its dominance in the Global Direct-to-Consumer (DTC) Genetic Testing Market owing to factors such as widespread consumer awareness, favorable regulatory environments, and a robust healthcare infrastructure. The region's tech-savvy population and high disposable income significantly contribute to its substantial market share, as consumers increasingly seek personalized genetic insights. The presence of key market players, active promotion of DTC genetic testing services, and a culture of early technology adoption further bolster North America's leadership position. Collaborative efforts between DTC genetic testing companies and research institutions also enhance the region's status as a hub for genetic testing innovations and advancements.

Key Market Players

23andMe, Inc

Ancestry.com, LLC

Color Health, Inc

Helix, Inc.

Counsyl, Inc.

MyHeritage Ltd.

Living DNA Ltd.

Mapmygenome India Limited

Full Genomes Corporation, Inc

Direct Laboratory Services, LLC

Report Scope:

In this report, the Global Direct-To-Consumer (DTC) Genetic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Direct-To-Consumer (DTC) Genetic Testing Market,By Test Type:

• Ancestry Relationship Testing
• Predictive Testing
• Nutrigenomic Testing
• Carrier Testing
• Skincare Testing
• Others

Direct-To-Consumer (DTC) Genetic Testing Market,By Technology:

• Single Nucleotide Polymorphism (SP) chips
• Targeted Analysis
• Whole Genome Sequencing (WGS)
• Others

Direct-To-Consumer (DTC) Genetic Testing Market,By Sample:

• Saliva
• Urine
• Blood
• Others

Direct-To-Consumer (DTC) Genetic Testing Market,By Distribution Channel:

• Online
• Offline

Direct-To-Consumer (DTC) Genetic Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Direct-To-Consumer (DTC) Genetic Testing Market.

Available Customizations:

Global Direct-To-Consumer (DTC) Genetic Testing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 4.1.Market Size Forecast
  • 4.1.1.By Value
• 4.2.Market Share Forecast
  • 4.2.1.By Test Type (Ancestry Relationship Testing, Predictive Testing, Nutrigenomic Testing, Carrier Testing, Skincare Testing, Others)
  • 4.2.2.By Technology (Single Nucleotide Polymorphism (SP) chips, Targeted Analysis, Whole Genome Sequencing (WGS), Others)
  • 4.2.3.By Sample (Saliva, Urine, Blood, Others)
  • 4.2.4.By Distribution Channel (Online, Offline)
  • 4.2.5.By Region
  • 4.2.6.By Company (2023)
• 4.3.Market Map

5.Asia Pacific Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Test Type
  • 5.2.2.By Technology
  • 5.2.3.By Sample
  • 5.2.4.By Distribution Channel
  • 5.2.5.By Country
• 5.3.Asia Pacific: Country Analysis
  • 5.3.1.China Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 5.3.1.1.Market Size Forecast
      • 5.3.1.1.1.By Value
    • 5.3.1.2.Market Share Forecast
      • 5.3.1.2.1.By Test Type
      • 5.3.1.2.2.By Technology
      • 5.3.1.2.3.By Sample
      • 5.3.1.2.4.By Distribution Channel
  • 5.3.2.India Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 5.3.2.1.Market Size Forecast
      • 5.3.2.1.1.By Value
    • 5.3.2.2.Market Share Forecast
      • 5.3.2.2.1.By Test Type
      • 5.3.2.2.2.By Technology
      • 5.3.2.2.3.By Sample
      • 5.3.2.2.4.By Distribution Channel
  • 5.3.3.Australia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 5.3.3.1.Market Size Forecast
      • 5.3.3.1.1.By Value
    • 5.3.3.2.Market Share Forecast
      • 5.3.3.2.1.By Test Type
      • 5.3.3.2.2.By Technology
      • 5.3.3.2.3.By Sample
      • 5.3.3.2.4.By Distribution Channel
  • 5.3.4.Japan Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 5.3.4.1.Market Size Forecast
      • 5.3.4.1.1.By Value
    • 5.3.4.2.Market Share Forecast
      • 5.3.4.2.1.By Test Type
      • 5.3.4.2.2.By Technology
      • 5.3.4.2.3.By Sample
      • 5.3.4.2.4.By Distribution Channel
  • 5.3.5.South Korea Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 5.3.5.1.Market Size Forecast
      • 5.3.5.1.1.By Value
    • 5.3.5.2.Market Share Forecast
      • 5.3.5.2.1.By Test Type
      • 5.3.5.2.2.By Technology
      • 5.3.5.2.3.By Sample
      • 5.3.5.2.4.By Distribution Channel

6.Europe Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.By Test Type
  • 6.2.2.By Technology
  • 6.2.3.By Sample
  • 6.2.4.By Distribution Channel
  • 6.2.5.By Country
• 6.3.Europe: Country Analysis
  • 6.3.1.France Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Test Type
      • 6.3.1.2.2.By Technology
      • 6.3.1.2.3.By Sample
      • 6.3.1.2.4.By Distribution Channel
  • 6.3.2.Germany Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Test Type
      • 6.3.2.2.2.By Technology
      • 6.3.2.2.3.By Sample
      • 6.3.2.2.4.By Distribution Channel
  • 6.3.3.Spain Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Test Type
      • 6.3.3.2.2.By Technology
      • 6.3.3.2.3.By Sample
      • 6.3.3.2.4.By Distribution Channel
  • 6.3.4.Italy Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.4.1.Market Size Forecast
      • 6.3.4.1.1.By Value
    • 6.3.4.2.Market Share Forecast
      • 6.3.4.2.1.By Test Type
      • 6.3.4.2.2.By Technology
      • 6.3.4.2.3.By Sample
      • 6.3.4.2.4.By Distribution Channel
  • 6.3.5.United Kingdom Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 6.3.5.1.Market Size Forecast
      • 6.3.5.1.1.By Value
    • 6.3.5.2.Market Share Forecast
      • 6.3.5.2.1.By Test Type
      • 6.3.5.2.2.By Technology
      • 6.3.5.2.3.By Sample
      • 6.3.5.2.4.By Distribution Channel

7.North America Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Test Type
  • 7.2.2.By Technology
  • 7.2.3.By Sample
  • 7.2.4.By Distribution Channel
  • 7.2.5.By Country
• 7.3.North America: Country Analysis
  • 7.3.1.United States Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Test Type
      • 7.3.1.2.2.By Technology
      • 7.3.1.2.3.By Sample
      • 7.3.1.2.4.By Distribution Channel
  • 7.3.2.Mexico Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Test Type
      • 7.3.2.2.2.By Technology
      • 7.3.2.2.3.By Sample
      • 7.3.2.2.4.By Distribution Channel
  • 7.3.3.Canada Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Test Type
      • 7.3.3.2.2.By Technology
      • 7.3.3.2.3.By Sample
      • 7.3.3.2.4.By Distribution Channel

8.South America Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Test Type
  • 8.2.2.By Technology
  • 8.2.3.By Sample
  • 8.2.4.By Distribution Channel
  • 8.2.5.By Country
• 8.3.South America: Country Analysis
  • 8.3.1.Brazil Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Test Type
      • 8.3.1.2.2.By Technology
      • 8.3.1.2.3.By Sample
      • 8.3.1.2.4.By Distribution Channel
  • 8.3.2.Argentina Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Test Type
      • 8.3.2.2.2.By Technology
      • 8.3.2.2.3.By Sample
      • 8.3.2.2.4.By Distribution Channel
  • 8.3.3.Colombia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Test Type
      • 8.3.3.2.2.By Technology
      • 8.3.3.2.3.By Sample
      • 8.3.3.2.4.By Distribution Channel

9.Middle East and Africa Direct-To-Consumer (DTC) Genetic Testing Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Test Type
  • 9.2.2.By Technology
  • 9.2.3.By Sample
  • 9.2.4.By Distribution Channel
  • 9.2.5.By Country
• 9.3.MEA: Country Analysis
  • 9.3.1.South Africa Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Test Type
      • 9.3.1.2.2.By Technology
      • 9.3.1.2.3.By Sample
      • 9.3.1.2.4.By Distribution Channel
  • 9.3.2.Saudi Arabia Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Test Type
      • 9.3.2.2.2.By Technology
      • 9.3.2.2.3.By Sample
      • 9.3.2.2.4.By Distribution Channel
  • 9.3.3.UAE Direct-To-Consumer (DTC) Genetic Testing Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Test Type
      • 9.3.3.2.2.By Technology
      • 9.3.3.2.3.By Sample
      • 9.3.3.2.4.By Distribution Channel

10.Market Dynamics

• 10.1.Drivers
• 10.2.Challenges

11.Market Trends Developments

• 11.1.Recent Developments
• 11.2.Product Launches
• 11.3.Mergers Acquisitions

12.Global Direct-To-Consumer (DTC) Genetic Testing Market: SWOT Analysis

13.Porter's Five Forces Analysis

• 13.1.Competition in the Industry
• 13.2.Potential of New Entrants
• 13.3.Power of Suppliers
• 13.4.Power of Customers
• 13.5.Threat of Substitute Product

14.Competitive Landscape

• 14.1.23andMe, Inc
  • 14.1.1.Business Overview
  • 14.1.2.Company Snapshot
  • 14.1.3.Products Services
  • 14.1.4.Financials (As Reported)
  • 14.1.5.Recent Developments
• 14.2.Ancestry.com, LLC
• 14.3.Color Health, Inc
• 14.4.Helix, Inc.
• 14.5.Counsyl, Inc.
• 14.6.MyHeritage Ltd.
• 14.7.Living DNA Ltd.
• 14.8.Mapmygenome India Limited
• 14.9.Full Genomes Corporation, Inc
• 14.10.Direct Laboratory Services, LLC

15.Strategic Recommendations

16.About Us Disclaimer